Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock

Critical Care Medicine

Volumn 38, Issue 10, 2010, Pages 1962-1969

  Siami, Shidasp ^a   Bailly Salin, Juliette ^b   Polito, Andrea ^b   Porcher, Raphael ^c   Blanchard, Anne ^d   Haymann, Jean Philippe ^e   Laborde, Kathleen ^f   Maxime, Virginie ^b   Boucly, Catherine ^b   Carlier, Robert ^b   Annane, Djillali ^b   Sharshar, Tarek ^b  

^a Sud Essonne Hospital   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e HÔPITAL TENON   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

osmoregulation; osmotic challenge; septic shock; sodium; vasopressin

Indexed keywords

ARGIPRESSIN; SODIUM; VASOPRESSIN; CALCITONIN; CORTICOTROPIN; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; PROCALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER DYSFUNCTION; MALE; OSMOREGULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; SODIUM BLOOD LEVEL; VASOPRESSIN RELEASE; BLOOD; BLOOD PRESSURE; ELECTROLYTE BALANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SEVERITY OF ILLNESS INDEX;

ADRENOCORTICOTROPIC HORMONE; AGED; ARGININE VASOPRESSIN; BLOOD PRESSURE; CALCITONIN; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 77957222522     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181eb9acf     Document Type: Article

References (53)

1. Annane D, Aegerter P, Jars-Guincestre MC, et al: Current epidemiology of septic shock: The CUB-Rea Network. Am J Respir Crit Care Med 2003; 168:165-172
2. Jochberger S, Mayr VD, Luckner G, et al: Serum vasopressin concentrations in critically ill patients. Crit Care Med 2006; 34: 293-299
3. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the va-sodilation of septic shock. Circulation 1997; 95:1122-1125
4. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydro-cortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
5. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758
6. Jochberger S, Dorler J, Luckner G, et al: The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 2009; 37:476-482
7. Luk J, Ajaelo I, Wong V, et al: Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate. Am J Physiol 1993; 265:R524-529
8. Russell JA: Vasopressin in septic shock. Crit Care Med 2007; 35(9 Suppl):S609-S615
9. Sharshar T, Annane D: Endocrine effects of vasopressin in critically ill patients. Best Pract Res Clin Anaesthesiol 2008; 22: 265-273
10. Lange M, Ertmer C, Westphal M: Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 2008; 34:821-832
11. Lauzier F, Levy B, Lamarre P, et al: Vasopres-sin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006; 32:1782-1789
12. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276-1291
13. Russell JA, Walley KR, Singer J, et al: Vaso-pressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
14. Sharshar T, Carlier R, Blanchard A, et al: Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002; 30:497-500
15. Sonneville R, Guidoux C, Barrett L, et al: Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock. Brain Pathol 2010; 20:613-622
16. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-1002
17. Giusti-Paiva A, Martinez MR, Bispo-da-Silva LB, et al: Vasopressin mediates the pressor effect of hypertonic saline solution in endo-toxic shock. Shock 2007; 27:416-421
18. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101:1481-1483
19. Thibonnier M, Sassano P, Daufresne S, et al: Osmoregulation and renal effects of vaso-pressin in normal and mildly hypertensive subjects. Kidney Int 1984; 25:411-415
20. Schrier RW, Berl T, Anderson RJ: Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979; 236:F321-F332
21. Caillens H, Paillard F, Rousselet F: [Study and development of a radioimmunoassay of antidiuretic hormone sensitive at 10(-12) M]. [Article in French.] Ann Pharm Fr 1982; 40:113-123
22. Pruszczynski W, Vahanian A, Ardaillou R, et al: Role of antidiuretic hormone in impaired water excretion of patients with congestive heart failure. J Clin Endocrinol Metab 1984; 58:599-605
23. Annane D, Bellissant E: Prognostic value of cortisol response in septic shock. JAMA 2000; 284:308-309
24. McCabe WR, Jackson GG: Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 1962; 110:847-855
25. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multi-center study. JAMA 1993; 270:2957-2963
26. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
27. Azizi M, Iturrioz X, Blanchard A, et al: Reciprocal regulation of plasma apelin and va-sopressin by osmotic stimuli. J Am Soc Nephrol 2008; 19:1015-1024
28. Schwarz G: Estimating the dimension of a model. Annals of Statistics 1978; 6:461-464
29. Davidian M, Giltinan DM: Nonlinear Models for Repeated Measurement Data. Monographs on Statistics and Applied Probability. Boca-Raton, Chapman & Hall/CRC, 1995
30. Pinheiro JC, Bates DM: Mixed-Effect Models in S and S-PLUS. New York, Springer, 2000
31. Ellison DH, Berl T: Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356:2064-2072
32. Kadekaro M, Summy-Long JY: Centrally produced nitric oxide and the regulation of body fluid and blood pressure homeostases. Clin Exp Pharmacol Physiol 2000; 27:450-459
33. Gillard ER, Coburn CG, de Leon A, et al: Vasopressin autoreceptors and nitric oxide-dependent glutamate release are required for somatodendritic vasopressin release from rat magnocellular neuroendocrine cells responding to osmotic stimuli. Endocrinology 2007; 148:479-489
34. Kadekaro M, Liu H, Terrell ML, et al: Role of NO on vasopressin and oxytocin release and blood pressure responses during osmotic stimulation in rats. Am J Physiol 1997; 273: R1024-R1030
35. Liu H, Terrell ML, Bui V, et al: Nitric oxide control of drinking, vasopressin and oxytocin release and blood pressure in dehydrated rats. Physiol Behav 1998; 63:763-769
36. Skujins A, Thorn NA: The NO synthase inhibitor L-NNA depresses neurohypophysial vasopressin but not its precursor amidating enzymes in salt-loaded rats. Acta Physiol Scand 1995; 155:243-250
37. Grinevich V, Ma XM, Jirikowski G, et al: Lipopolysaccharide endotoxin potentiates the effect of osmotic stimulation on vaso-pressin synthesis and secretion in the rat hypothalamus. J Neuroendocrinol 2003; 15: 141-149
38. Bundzikova J, Pirnik Z, Zelena D, et al: Response of substances co-expressed in hypo-thalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats. Cell Mol Neurobiol 2008; 28:1033-1047
39. Callewaere C, Banisadr G, Desarmenien MG, et al: The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc Nat Acad Sci\USA 2006; 103:8221-8226
40. Furuya K, Shimizu R, Hirabayashi Y, et al: Stress hormone responses to major intra-abdominal surgery during and immediately after sevoflurane-nitrous oxide anaesthesia in elderly patients. Can J Anaesth 1993; 40: 435-439
41. Goldmann A, Hoehne C, Fritz GA, et al: Combined vs isoflurane/fentanyl anesthesia for major abdominal surgery: Effects on hormones and hemodynamics. Med Sci Monit 2008; 14:CR445-CR452
42. Kozawa O, Tanabe K, Matsuno H, et al: Pentobarbital, but not propofol, suppresses vaso-pressin-stimulated heat shock protein 27 induction in aortic smooth muscle cells. Anesthesiology 2000; 92:1807-1813
43. Nishiyama T, Yamashita K, Yokoyama T: Stress hormone changes in general anesthesia of long duration: Isoflurane-nitrous oxide vs sevoflurane-nitrous oxide anesthesia. J Clin Anesth 2005; 17:586-591
44. Winterhalter M, Brandl K, Rahe-Meyer N, et al: Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl. Eur J Anaesthesiol 2008; 25:326-335
45. Cross JS, Gruber DP, Gann DS, et al: Hyper-tonic saline attenuates the hormonal response to injury. Ann Surg 1989; 209: 684-691; discussions, 691-1682
46. Kolsen-Petersen JA, Bendtzen K, Tonnesen E: Infusion of hypertonic saline before elective hysterectomy: Effects on cytokines and stress hormones. Br J Anaesth 2008; 100: 478-484
47. Choi-Kwon S, McCarty R, Baertschi AJ: Splanchnic control of vasopressin secretion in conscious rats. Am J Physiol 1990; 259: E19-E26
48. Bohus B, de Wied D: The vasopressin deficient Brattleboro rats: A natural knockout model used in the search for CNS effects of vasopressin. Prog Brain Res 1998; 119: 555-573
49. Hasser EM, Cunningham JT, Sullivan MJ, et al: Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II. Clin Exp Pharmacol Physiol 2000; 27: 432-436
50. Huber D, Veinante P, Stoop R: Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005; 308:245-248
51. Oliveira RP, Velasco I, Soriano F, et al: Clinical review: Hypertonic saline resuscitation in sepsis. Crit Care 2002; 6:418-423
52. Shih CC, Chen SJ, Chen A, et al: Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. Crit Care Med 2008; 36:1864-1872
53. McCabe WA, Jackson GG. Gram negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110: 847-855